UNSPSC 51332849: Fluphenazine dihydrochloride

This classification denotes an antipsychotic agent with the molecular formula C22H26F3N3OS.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZOU145W1XL, chemically known as 1-piperazineethanol, 4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)- but more generally known as fluphenazine dihydrochloride, which bears US NIH Compound Identifier 3372. European Medicines Agency schedules Fluphenazine dihydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02232MIG.

Most nations, for tariff and trade purposes, schedule fluphenazine dihydrochloride under HS 29343090. SMILES: C1CCC2C(C1)N(C3CC(CCC3S2)C(F)(F)F)CCCN4CCN(CC4)CCO.CL.CL.

UNSPSC 51332849 Fluphenazine dihydrochloride, a Commodity code, shows minimal alignment with actual state and local procurement activity. The code nominally describes a specific pharmaceutical compound used in antipsychotic treatment; however, the single recent opportunity sourced under this code—Seminole County, Florida's IFB 60459723LAS posted June 30, 2026—solicits Naloxone and Safe Drug Deactivation Systems, products entirely unrelated to fluphenazine dihydrochloride. This mismatch suggests either miscoding in the county's procurement system or that the code is not being used consistently for its intended pharmaceutical scope.

The Seminole County IFB calls for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must submit bids electronically through the county's e-Procurement Portal, include all shipping and delivery costs, comply with drug-free workplace certification and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract carries a two-year initial term with a one-year renewal option and a three-month probationary period allowing termination with or without cause. The source indicates potential FEMA funding with attendant federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act. Based on available records, this code shows little relevant recent activity and appears underutilized for its stated pharmaceutical category.